Loading clinical trials...
Loading clinical trials...
A 48-week Multi-centre, Open-label, Local Phase IV Study to Demonstrate the Efficacy and Safety of Adefovir Dipivoxil Tablets (10mg) in Chinese Subjects With Compensated Chronic Hepatitis B
Conditions
Interventions
adefovir dipivoxil
Locations
25
China
GSK Investigational Site
Guangzhou, Guangdong, China
GSK Investigational Site
Guangzhou, Guangdong, China
GSK Investigational Site
Wuhan, Hubei, China
GSK Investigational Site
Nanjing, Jiangsu, China
GSK Investigational Site
Nanjing, Jiangsu, China
GSK Investigational Site
Nanjing, Jiangsu, China
Start Date
December 1, 2006
Primary Completion Date
September 1, 2008
Completion Date
September 1, 2008
Last Updated
October 20, 2009
NCT06671093
NCT06885710
NCT06263959
NCT06295328
NCT02883647
NCT04139850
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions